HLA-C and neoplasm: In contrast to the T-cell receptor (TCR) structure of conventional T cells, the CAR structure is independent of the major histocompatibility complex (MHC) antigen presentation, avoids restriction by MHC molecules, and solves the problem of tumor immune escape due to downregulation of MHC (67) (Figure 2).